Tristel Investor
Tristel proprietary chlorine dioxide (ClO₂): providing high-level disinfection in medical, pharmaceutical, veterinary and laboratory settings.
Founded Date:
1998-01-01
Headquarters:
Snailwell, United Kingdom
Investors Number:
2
Employee Number:
51-100
Industry:
Manufacturing, Medical Device
Estimated Revenue:
$10M to $50M
Number Of Exists:
N/A
Funding Status:
IPO
Investor Type:
N/A
Investment Stage:
Undisclosed